CD4 and lymphopenia: He was found to have no detectable IgA and IgM (even at 1 year after receiving his first rituximab treatment), and he developed progressive B and T cell lymphopenia (including low naïve CD4 T-cell count and ratio of naïve to memory CD4 T cells).